SOFTX logo

SoftOx Solutions AS Stock Price

OB:SOFTX Community·NOK 270.1m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

SOFTX Share Price Performance

NOK 0.10
-0.02 (-15.95%)
NOK 0.10
-0.02 (-15.95%)
Price NOK 0.10

SOFTX Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with slight risk.

4 Risks
1 Reward

SoftOx Solutions AS Key Details

NOK 16.3m

Revenue

NOK 0

Cost of Revenue

NOK 16.3m

Gross Profit

NOK 34.1m

Other Expenses

-NOK 17.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Sep 23, 2026
-0.0069
100.00%
-109.83%
0%
View Full Analysis

About SOFTX

Founded
2012
Employees
2
CEO
Thomas Bjarnsholt
WebsiteView website
soft-ox.com

SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that anti-infective therapy for airway infections in Norway. The company develops SIS-03, a lead clinical program that is in phase 2a to treatment of chronic airway infections. It also developing pan antimicrobial pharmaceuticals targeting bacteria, viruses, yeast, spores, and fungi. SoftOx Solutions AS was founded in 2012 and is based in Lysaker, Norway.

Recent SOFTX News & Updates

Recent updates

No updates